Best Ingmar Podcasts (2025)

1
The Eclipse Viewer – Episode 65 – Abbas Kiarostami: Early Shorts and Features [Part 2]

Play Pause

10d ago

—

This podcast focuses on the Eclipse Series, box set editions of lost, forgotten, or overshadowed films recently revived by the Criterion Collection. Hosts David Blakeslee and Trevor Berrett give an overview of each set and offer their perspectives on the unique treasures they find inside. In this episode, David and Trevor discuss two films (Experie…

1
The Eclipse Viewer – Episode 65 – Abbas Kiarostami: Early Shorts and Features [Part 2]

10d ago

—

This podcast focuses on the Eclipse Series, box set editions of lost, forgotten, or overshadowed films recently revived by the Criterion Collection. Hosts David Blakeslee and Trevor Berrett give an overview of each set and offer their perspectives on the unique treasures they find inside. In this episode, David and Trevor discuss two films (Experie…

1
Werner Lanthaler 🇦🇹 | Biopharma AI, CDMO, Antibody Optimization | E48 59:34

24d ago59:34

59:34

1
The Eclipse Viewer – Episode 64 – Abbas Kiarostami: Early Shorts and Features [Part 1]

30d ago

—

This podcast focuses on the Eclipse Series, Blu-ray box set editions of lost, forgotten, or overshadowed films recently revived by the Criterion Collection. Hosts David Blakeslee and Trevor Berrett give an overview of each set and offer their perspectives on the unique treasures they find inside. In this episode, David and Trevor discuss four films…

1
The Eclipse Viewer – Episode 64 – Abbas Kiarostami: Early Shorts and Features [Part 1]

29d ago

—

This podcast focuses on the Eclipse Series, Blu-ray box set editions of lost, forgotten, or overshadowed films recently revived by the Criterion Collection. Hosts David Blakeslee and Trevor Berrett give an overview of each set and offer their perspectives on the unique treasures they find inside. In this episode, David and Trevor discuss four films…

1
Thomas Lingelbach, Valneva | Vaccines, Lyme Disease | E47 44:27

1M ago44:27

44:27

Valneva now has three commercialized vaccines, and a Lyme disease candidate in Phase 3. Philip quizzes CEO Thomas Lingelbach about everything. They also discuss the current political turbulence with vaccines, especially in the US, and how it is impacting the industry.⭐️ ABOUT THE SPEAKERA veteran in the development of more than ten vaccines, Thomas…

1
Ingmar Jungnickel on AiRO and Scalable Aerodynamic Testing 1:25:32

1M ago1:25:32

1:25:32

Sports aerodynamicist Ingmar Jungnickel joins the show to discuss AiRO, a new CFD-based aero analysis tool built for bike fitters and coaches. He outlines why traditional wind-tunnel and field-testing approaches struggle with cost, complexity, and repeatability, and explains how recent advances in computing and AI now make high-fidelity CFD practic…

1
Marc de Garidel, Abivax 🇫🇷 | Ulcerative Colitis, Inflammation | E46 53:40

1M ago53:40

53:40

When Abivax released stunning phase 3 results for ulcerative colitis, its 600% stock price surge froze Euronext for 45 minutes. Philip meets Abivax CEO Marc de Garidel in Vienna, Austria, to go behind the scenes of a remarkable biotech turnaround. Marc discusses the processes involved in executing the phase 3 trial that beat even Abivax’s own phase…

1
Coach Russ Cox on Qualifying for the Ironman World Championship 1:03:07

1M ago1:03:07

1:03:07

Michael welcomes UK-based triathlon coach and data analyst Russ Cox to unpack Ironman’s major overhaul of its World Championship slot allocation system. Drawing on his 14 years of statistical modeling and 16 years of coaching experience, Russ explains how Ironman’s shift from participation-based to performance-adjusted qualification is reshaping wh…

1
Laurent Levy, Nanobiotix 🇫🇷 | Nanoparticles, Radiotherapy | E45 50:03

2M ago50:03

50:03

As Philip travels to France, Nanobiotix CEO Laurent Lévy discusses how the company broke into Europe’s exclusive $1 billion biotech club, alongside the likes of Abivax and Medincell. They also chat about what it means to partner with giants like Johnson & Johnson, and how Laurent’s leadership style has evolved over his long tenure. ⭐️ ABOUT THE SPE…

1
Gerrit Sitters, LUMICKS 🇳🇱 | CAR-T therapy, Single-Cell Analysis | E44 [Sponsored] 1:24:33

2M ago1:24:33

1:24:33

As Philip tours Amsterdam, he visits the biotech tools startup LUMICKS. Founded in 2014, the firm offers products analyzing the binding interactions between molecules and cells, with applications in drug development, CAR-T therapies, and manufacturing. Philip sits down with co-founder Gerrit Sitters to discuss the company’s trajectory, the cyclic b…

1
Fabrice Chouraqui, Pharming 🇳🇱 | Transgenic Rabbits, Rare Diseases | E43 54:48

2M ago54:48

54:48

We travel to the offices of Pharming Group in Leiden, the Netherlands, to chat with the newcomer CEO Fabrice Chouraqui. Fabrice discusses the fascinating history of Pharming, with its first commercial drug RUCONEST produced in the milk of transgenic rabbits. He also talks about the growth of Pharming from a protein therapy-focused biotech into a Eu…

1
Introducing “The Black Thread” 1:35

3M ago1:35

1:35

The Black Thread is a new documentary podcast series unravelling Norway’s complex relationship with prosperity, identity, and responsibility in a warming world. Episodes will be dropping weekly over on Drilled Media.By Communicating Climate Change

1
Daniela Marino, CUTISS 🇨🇭 | Tissue Engineering, Skin Grafts | E42 [Sponsored] 1:07:40

2M ago1:07:40

1:07:40

Hot on the heels of CUTISS’ $60M Series C round, we catch up once more with CEO and co-founder Daniela Marino. We chat about the company’s mission to develop an engineered tissue therapy to reduce the need for skin grafts in patients with severe burns. She also explains the decentralization of tissue manufacturing with automation and the need for p…

1
Dragan Grabulovski, Araris 🇨🇭 | ADC Linkers, Replacing Chemotherapy | E41 1:08:49

3M ago1:08:49

1:08:49

Philip meets up with Dragan Grabulovski, CEO of the startup Araris, at Lake Zurich to chat about the company’s work with antibody-drug conjugates (ADCs).They talk about Araris’ huge $400M upfront buyout by Taiho Pharma of Japan, Dragan’s extensive history as a biotech entrepreneur, and Araris’ vision to replace chemotherapy with ADCs.⭐️ ABOUT THE S…

1
Jamie Pugh of EXO Analytics on Carbohydrate Utilization 53:21

3M ago53:21

53:21

By Michael Liberzon

1
Stefano Portolano, Azafaros 🇳🇱 🇨🇭 | Rare Diseases, Small Molecules | E40 1:18:34

3M ago1:18:34

1:18:34

On a trip to Basel, Switzerland, Philip catches up with Stefano Portolano, CEO of the European firm Azafaros. They chat about Azafaros’ massive $147M Series B round in May 2025, which is being used to develop a small molecule treatment for rare diseases known as lysosomal storage disorders.Stefano also explains how rare diseases went in and out of …

1
Alex Zhavoronkov, Insilico Medicine | AI Drug Development, Longevity | E39 58:02

3M ago58:02

58:02

We chat about longevity with Alex Zhavoronkov, CEO and founder of the artificial intelligence (AI) specialist Insilico Medicine. Born in Latvia, Alex founded Insilico in 2014, with the company raising a huge $110M Series E round this year. Alex gives us a tour of Insilico’s sprawling pipeline, a blunt rundown of the competitive landscape in AI drug…

1
THE NINTH GATE (1999) — There is no Hell, There is only Toledo. 4:12:41

4M ago4:12:41

4:12:41

*NEW!* On this episodes annotated deep dive, The Cultists present Roman Polanski’s The Ninth Gate (1999). A slow and cozy burn of paranoia through warm-lit and dusty streets, The Ninth Gate tells that classic tale of a bored and bitter book dealing mercenary who happens upon an ancient esoteric puzzle concealed in the pages of the text — a one shot…

1
TWILIGHT(2008) - Some Like It Cold. 2:58:57

4M ago2:58:57

2:58:57

**REPOST** On this week's annotated deep-dive, The Cultists present Catherine Hardwick's wondrously absurd adaptation of Twilight (2008). The tale of a self-loathing undead stalker who has been stuck repeating high school for one hundred years, and the clumsy death-welcoming teen of his dreams, Twilight is a wild trip. Known as the phenomenon that …

1
BLUE VELVET (1986) — Get Behind Me, Oedipus! 2:46:57

4M ago2:46:57

2:46:57

**REPOST** For our one year anniversary episode, The Cultists present David Lynch’s ‘Blue Velvet’ (1986). Yet another film that was met with a mixture of confusion, repulsion, and awe upon its release into the center of the Regan era and big blockbuster productions, BV has since become something of a noted surrealist masterpiece of avant-garde cine…

1
ROMEO+JULIET (1996) — I defy you, Dopamine!! 2:55:08

4M ago2:55:08

2:55:08

**REPOST** On this week’s annotated deep dive, The Cultists present Baz Lurman’s 90s frenetic teen angst extravaganza, Romeo + Juliet (1996). Known for his kinetic color-fueled explosions of images and sound, Lurman’s “red curtain trilogy” put him on the film world’s map as an Auteur with a distinct and immediately recognizable style. Bright, brash…

1
MIDSOMMAR (2019)—Ingmar Bergman told me there’d be days like these. 2:07:10

4M ago2:07:10

2:07:10

**REPOST** On this week’s annotated deep dive, The Cultists Present Ari Aster’s ‘Midsommar’ (2019). The horror genre has long been a place of shadows. And yet, what happens when those horrors are brought into direct light? Can grief, heartbreak, graduate thesis work, and human sacrifice all still thrive under the warm glowing rays of the midnight s…

1
EYES WIDE SHUT (1999)—Thus Spoke Stanley Kubrick (Part II) 1:37:00

4M ago1:37:00

1:37:00

**REPOST** On this week’s annotated deep dive, The Cultists continue to present Stanley Kubrick’s final film Eyes Wide Shut (1999). ***THIS IS PART TWO OF A TWO PART EPISODE*** Deep Dives Include: production history; comparisons with the film’s “Dream Story” (1926) novella source material ; the Gustav Klimt color pallet; the meaning behind those ne…

1
Robin Carr, Myricx Bio 🇬🇧 | New ADC Payloads, London Biotech Startups | E38 58:22

4M ago58:22

58:22

We jet off to Central London to meet Robin Carr, CEO of Myricx Bio, a startup developing antibody-drug conjugates (ADCs) to treat cancer. The team’s idea – using a novel ADC payload inhibiting molecules called N-myristoyltransferases (NMTs) – helped them to bag an impressive £90M ($114M) Series A round in 2024. Robin outlines Myricx’s journey from …

1
David Reviews Mike Nichols’s Carnal Knowledge [Criterion 4K/Blu-ray Review]

5M ago

—

A new release from the Criterion Collection represents yet another successful retrieval of an important film originally released by that company on the Laserdisc format they specialized in for 15 years or so before they started releasing movies on DVD. Carnal Knowledge, Mike Nichols’ 1971 follow up to Catch-22, functioned as a lightning rod for can…

1
David Reviews Mike Nichols’s Carnal Knowledge [Criterion 4K/Blu-ray Review]

5M ago

—

A new release from the Criterion Collection represents yet another successful retrieval of an important film originally released by that company on the Laserdisc format they specialized in for 15 years or so before they started releasing movies on DVD. Carnal Knowledge, Mike Nichols’ 1971 follow up to Catch-22, functioned as a lightning rod for can…

1
David Reviews Mike Nichols’s Carnal Knowledge [Criterion 4K/Blu-ray Review]

5M ago

—

A new release from the Criterion Collection represents yet another successful retrieval of an important film originally released by that company on the Laserdisc format they specialized in for 15 years or so before they started releasing movies on DVD. Carnal Knowledge, Mike Nichols’ 1971 follow up to Catch-22, functioned as a lightning rod for can…

1
Aino Kalervo, TILT Biotherapeutics 🇫🇮 | Immunotherapy, Oncolytic Virus | E37 [Sponsored] 49:17

5M ago49:17

49:17

We dive into the world of cutting-edge cancer treatments with Aino Kalervo, Chief Operating Officer of TILT Biotherapeutics and occasional tennis legend in her spare time.TILT recently closed a $25M series B round, backed by leading Finnish investors, to finance the clinical development of its oncolytic virus candidate to supercharge cancer immunot…

1
Criterion Reflections – Episode 156 – Ingmar Bergman’s Scenes From a Marriage

6M ago

—

https://criterioncast.com/wp-content/uploads/1751/28/Criterion-Reflections-Episode-156-Scenes-From-a-Marriage.mp3 Criterion Reflections is David Blakeslee’s ongoing project to watch all of the films included in the Criterion Collection in chronological order of their original release. Each episode of Season 5: 1973 features a discussion about films…

1
Criterion Reflections – Episode 156 – Ingmar Bergman’s Scenes From a Marriage

6M ago

—

https://criterioncast.com/wp-content/uploads/1751/28/Criterion-Reflections-Episode-156-Scenes-From-a-Marriage.mp3 Criterion Reflections is David Blakeslee’s ongoing project to watch all of the films included in the Criterion Collection in chronological order of their original release. Each episode of Season 5: 1973 features a discussion about films…

1
Criterion Reflections – Episode 156 – Ingmar Bergman’s Scenes From a Marriage

6M ago

—

https://criterioncast.com/wp-content/uploads/1751/28/Criterion-Reflections-Episode-156-Scenes-From-a-Marriage.mp3 Criterion Reflections is David Blakeslee’s ongoing project to watch all of the films included in the Criterion Collection in chronological order of their original release. Each episode of Season 5: 1973 features a discussion about films…

1
Joe Staunton on Anthropocentric Coaching 1:08:13

6M ago1:08:13

1:08:13

By Michael Liberzon

1
Renee Aguiar-Lucander, Hansa Biopharma 🇸🇪 | Immunology, Gene therapy | E36 53:46

6M ago53:46

53:46

Fresh after leading Calliditas Therapeutics through a $1.1B acquisition, Renee Aguiar-Lucander takes us through her new CEO role at Hansa Biopharma 🇸🇪.We learn how Hansa is commercialising Idefirix, its lead product for improving outcomes in kidney transplantation. We also cover the hot area of immunology, the behind-the-scenes story behind Callidi…

1
Stephane Bancel, Moderna | mRNA Therapeutics, Boston Biotech Mafia, AI Biotech | E35 58:51

6M ago58:51

58:51

We’re with Stephane Bancel, CEO of the US mRNA giant Moderna. The company’s 15-year trajectory has taken it from the startup seed stage to a commercial heavyweight with three mRNA-based products in the market 🧬 We go in-depth into Stephane’s leadership style and background before delving into Moderna’s research and the evolution of the mRNA space. …

1
Sam Barley on Cycling Aero and Bike Fit 49:49

6M ago49:49

49:49

By Michael Liberzon

1
Insights From Interventions Within the Global Majority With Diya Deb 42:32

7M ago42:32

42:32

This episode features a conversation with Diya Deb, executive director of Mindworks. It was recorded in April 2025. Growing up as an activist in India, Diya has in-depth experience of working in harsh political and social realities. With a variety of leadership roles under her belt from Amnesty and Greenpeace India, and a background in campaigning …

1
Chris Martin, Verona Pharma 🇬🇧 | Ohtuvayre, COPD, Execution | E34 55:24

7M ago55:24

55:24

We’re online with Chris Martin, COO of the 6th most valuable biotech in Europe, Verona Pharma. Their amazing story sees them bring a fully-owned respiratory drug to market and multiply its valuation by 120x within the last 5 years (from $50M to $6B today) 💸We talk about the commercial rollout of Ohtuvayre, Verona’s drug. We also discuss the British…

1
Ronan McLaughlin on Bike Optimizaiton 57:56

7M ago57:56

57:56

By Michael Liberzon

1
Episode 217 – Argentine Noir with guest Matthew Gentile

7M ago

—

This episode of Criterion Cast features a conversation with director/screenwriter Matthew Gentile, as he and host David Blakeslee discuss the ARGENTINE NOIR bundle currently streaming on the Criterion Channel. As the name implies, this is a collection of six films noir originally released in Argentina during the 1950s. Here’s how the Channel descri…

1
Episode 217 – Argentine Noir with guest Matthew Gentile

7M ago

—

This episode of Criterion Cast features a conversation with director/screenwriter Matthew Gentile, as he and host David Blakeslee discuss the ARGENTINE NOIR bundle currently streaming on the Criterion Channel. As the name implies, this is a collection of six films noir originally released in Argentina during the 1950s. Here’s how the Channel descri…